Immatics
realizing the full cancer opportunity of | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
11 of 75
Related slides by other companies
Nuvectis Pharma
Investor Presentation
August 2023
phase underway fast track designation | Nuvectis Pharma
BioNTech
Results
November 2020
safety trial in patients with malignant solid tumors who are not bot | BioNTech
ATAI
Investor Presentation
March 2023
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk preliminary data subject to change phase the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
MindMed
Investor Presentation
November 2024
for gad phase study designs voyage panorama | MindMed
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights